VivoSeq
Other

Toothache

20

Pipeline Programs

0

Active Trials

11

Companies Involved

Toothache is an emerging landscape with 20 programs across 11 companies. The most active players are Daewon Pharmaceutical Co., Ltd., Haisco Pharmaceutical Group Co., Ltd., Kenvue Brands. 13 therapies are approved with 4 more in late-stage development.

Pipeline Metrics

Competitive Density

46/100

Pipeline Velocity

6/100

Mech. Concentration

47/100

Completion Rate

83/100

Attrition Rate

17/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

6

clinical trials

Completed5 · 83%
Terminated1 · 17%

Trial Activity

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)